These two work at opposite ends of the skin. Moxi is a laser. It sends light in at 1927 nm, a wavelength water absorbs almost immediately, so its effect stays in and just under the surface layer. Morpheus8 is not a laser at all. It drives fine needles into the deeper layer of skin and releases radiofrequency heat from their tips.
That means they are for different problems. Moxi is aimed at brown spots, dullness and early sun damage — colour you can see on the surface. Morpheus8 is aimed at texture, mild sagging and scarring, which sit deeper than this kind of light reaches.
The recovery differs in character, not just in length. Moxi gives redness on day one and then a bronzed, sandpapery feel through the middle of the week. Morpheus8 gives redness, swelling and a visible grid of needle marks. Neither is long, but they look and feel like different things, and one of them is harder to hide.
The regulatory position runs opposite to the marketing. Morpheus8's clearances name no cosmetic use at all: electrocoagulation and hemostasis — surgical language for sealing tissue and stopping bleeding — in December 2019 (K192695), then coagulation or contraction of soft tissue in July 2023 (K231790). The clearance behind Moxi does name conditions. Moxi is the 1927 nm module on Sciton's Joule platform, and the platform's clearance - K182173, granted 6 March 2019 - covers coagulation of soft tissue, treatment of actinic keratosis, which are rough patches caused by sun damage, and treatment of benign pigmented lesions such as lentigos (age spots), solar lentigos (sun spots) and ephelides (freckles). The trade name Moxi does not itself appear in the clearance; the device named there is the Joule 1927 nm laser system. Neither position proves anything works. A 510(k) clearance is a decision that a device is much like a device already on the market, not a finding of benefit.
Non-ablative means it heats the skin without removing the surface. Fractional means it treats in tiny columns, leaving untreated skin in between.
The pins are coated except for the last 0.5 mm, so the energy leaves at the tip rather than at the entry point in the surface.
A micron is a thousandth of a millimetre, so that is a fraction of a millimetre.
Those depths come from InMode's own operator manuals. The highest depth figure in any FDA document for this device is 7 mm.
That is the wording of K182173 (6 March 2019), which clears Sciton's Joule 1927 nm laser system - the platform Moxi runs on. Wrinkles, texture and melasma are not in it.
Acne scars, wrinkles, laxity, the jawline and the neck appear in no Morpheus8 clearance.
That is the conventional clinical description of this treatment rather than a measured figure from a trial.
In published studies of radiofrequency microneedling, redness occurred in every patient and swelling in about 30 per cent. One study put downtime at three to four days; another found skin barrier function back to normal by day seven.
No study has compared the comfort of these two treatments, so this is clinical description rather than a measured result.
Published protocols cluster at three sessions, spaced three to eight weeks apart. That is a convention carried between studies, not the result of anyone testing one session against three.
Clinics frequently offer these two together, and the reasoning is straightforward: each is aimed at a layer the other does not reach. Surface colour on one hand, deeper texture and support on the other.
Two honest caveats. First, no published trial has tested the two treatments together, so a package is best understood as two separate treatments with two separate reasons rather than one combined therapy with combined evidence. Second, a package prices and books as one thing, which makes it easy to lose track of what each part is for. Ask what each treatment is being used for on your face, and what you should see from each.
Almost none of it was generated on a Morpheus8. A PubMed search for the brand returns 16 records and no randomised controlled trial. The published research supporting radiofrequency microneedling comes from other machines — Lutronic Genius and Infini, Jeisys, Pollogen, Lumenis and several unnamed devices. The evidence for the class is real. It is simply not this brand's evidence, and anyone quoting study results at you under the Morpheus8 name should be able to say which device produced them.
It also runs out earlier than the marketing suggests. Six months after the last session is the longest properly measured follow-up in this literature. The "one to three years" figure that circulates in clinic copy has no published source.
The FDA keeps a database of postmarket reports for medical devices. A 2026 analysis of it covering radiofrequency microneedling from 2013 to 2025 found 114 reports containing 224 events. The most reported categories were textural changes (56 events), pigment change (41) and loss of fat under the skin (26).
Those are proportions of complaints, not risks. The database is voluntary and has no denominator — nobody knows how many treatments were performed — so none of those numbers can be turned into a chance that something happens to you. Set against the fat-loss reports, a separate 30-person study measured the fat layer under the chin by ultrasound after this kind of treatment and found it unchanged, while the skin above it thickened.
That analysis looked at radiofrequency microneedling devices only. It says nothing about Moxi in either direction.
If you get cold sores, say so when you book, not on the day. Antiviral medicine is started in advance, so it has to be prescribed beforehand. There is no published data on cold-sore reactivation after radiofrequency microneedling specifically; the precaution is carried over from laser resurfacing, where reactivation is well documented and prophylaxis is standard.
Tell the clinic about a pacemaker or an implantable defibrillator, and about any metal implant near the treatment area, before booking Morpheus8. These are labelled contraindications for radiofrequency devices, and they are precautionary rather than tested. Your cardiology team, not the clinic, is the right group to advise you.
If you have a deeper skin tone, ask what energy per pin is planned for Morpheus8. Its own clearance says that above 62 mJ per pin the applicator is limited to skin types I to IV, so higher settings in deeper phototypes fall outside the cleared labelling.